Adjuvant endocrine therapy is foundational in the treatment of hormone receptor–positive breast cancer, yet questions about duration, side effects, and long-term survivorship care remain common.

In this focused session, Dr. Corrine Menn will review current evidence guiding tamoxifen and aromatase inhibitor therapy, discuss extended treatment decisions, and address practical strategies for managing therapy-related symptoms. Emphasis will be placed on patient-centered counseling and supporting adherence across the survivorship continuum.

Corinne Menn, MD (Alloy) is a board-certified OBGYN and Menopause Society Certified Practitioner. She is also an over-23-year survivor of breast cancer and premature menopause, a BRCA carrier, and uses her experience to help women navigate their own health challenges. She has dedicated her medical practice to menopause management, the unique healthcare needs of female cancer survivors, and those at high risk for breast cancer. Now practicing exclusively through telehealth, Dr. Menn provides women’s health consultations and patient education. She is also a Medical Advisor and prescribing doctor on Alloy, a menopause telehealth platform.